Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer

Image: Sesen Bio has reported data update from phase 3 trial for high-risk non-muscle invasive bladder cancer. Photo: courtesy of Colin Behrens from Pixabay.